Fasting Study of Glipizide and Metformin HCl Tablets 5 mg/500 mg to Metaglip® Tablets 5 mg/500 mg

NCT00649454 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Glipizide and Metformin HCl Tablets 5 mg/500 mg
DRUG: Metaglip® Tablets 5 mg/500 mg

Sponsor

Mylan Pharmaceuticals Inc